Recombinant insulin has demonstrated significant value in vaccine manufacturing by improving cell culture performance, enhancing viral yield and supporting consistent production across diverse vaccine ...
Dr. Reddy’s launches Hevaxin, India’s first approved vaccine for preventing Hepatitis E virus infection in adults aged 18 to ...
From eradicating smallpox to battling the COVID-19 pandemic, these vaccine pioneers have helped make colossal strides in ...
“Our findings indicate that the vaccine provided a significant enhanced level of protection against these infections in the ...
Dr Reddy's launches Hevaxin, a novel recombinant hepatitis E vaccine in India: Our Bureau, Bengaluru Wednesday, January 7, 2026, 15:30 Hrs [IST] Dr Reddy’s Laboratories has laun ...
Foundation-funded project targets infectious bronchitis and infectious laryngotracheitis viruses.
To help protect yourself and your family from getting seriously ill, you may want to learn about additional vaccine options ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback